Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,496 | -25,490 | -18,568 | -12,366 | -6,162 |
| Depreciation Amortization | 1,176 | 2,986 | 2,125 | 1,369 | 670 |
| Accounts receivable | 82 | -161 | -104 | -51 | -39 |
| Accounts payable and accrued liabilities | 27 | -1 | 1,013 | 949 | 565 |
| Other Working Capital | 573 | -1,435 | -1,751 | 316 | -799 |
| Other Operating Activity | 1,028 | 5,507 | 3,332 | 2,004 | 906 |
| Operating Cash Flow | $-5,612 | $-18,593 | $-13,952 | $-7,778 | $-4,859 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,083 | -10,169 | -6,978 | -3,014 | -1,027 |
| Purchase Sale Intangibles | N/A | -24 | -24 | -23 | -23 |
| Other Investing Activity | 0 | -24 | -23 | -23 | -23 |
| Investing Cash Flow | $-1,083 | $-10,193 | $-7,002 | $-3,037 | $-1,050 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 31,278 | 14,804 | 233 | 74 | 6 |
| Common Stock Repurchased | -716 | -3,978 | -2,443 | -1,358 | N/A |
| Financing Cash Flow | $30,563 | $10,827 | $-2,210 | $-1,284 | $6 |
| Exchange Rate Effect | 119 | 276 | 203 | 145 | 13 |
| Beginning Cash Position | 21,568 | 39,252 | 39,252 | 39,252 | 39,252 |
| End Cash Position | 45,556 | 21,568 | 16,292 | 27,298 | 33,362 |
| Net Cash Flow | $23,988 | $-17,684 | $-22,960 | $-11,954 | $-5,891 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,612 | -18,593 | -13,952 | -7,778 | -4,859 |
| Capital Expenditure | -1,083 | -10,169 | -6,978 | -3,014 | -1,027 |
| Free Cash Flow | -6,695 | -28,763 | -20,930 | -10,792 | -5,886 |